Literature DB >> 64297

ICRF-159 versus polychemotherapy in non-small cell lung cancer.

R T Eagan, D T Carr, D T Coles, J Rubin, S Frytak.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1976        PMID： 64297

Source DB:  PubMed          Journal:  Cancer Treat Rep        ISSN： 0361-5960


× No keyword cloud information.
  3 in total

Review 1.  Combination chemotherapy for advanced adenocarcinoma of the lung. A review.

Authors:  J B Sørensen; H H Hansen
Journal:  Cancer Chemother Pharmacol       Date:  1988       Impact factor: 3.333

2.  Cisplatin, vinblastine, and bleomycin in inoperable non-small cell lung cancer.

Authors:  R Stuart-Harris; R M Fox; D Raghavan; A S Coates; D Hedley; J A Levi; R L Woods; M H Tattersall
Journal:  Thorax       Date:  1985-05       Impact factor: 9.139

Review 3.  Single-agent chemotherapy for advanced adenocarcinoma of the lung. A review.

Authors:  J B Sørensen; M Clerici; H H Hansen
Journal:  Cancer Chemother Pharmacol       Date:  1988       Impact factor: 3.333
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.